Increasing TET Expression and 5‐Hydroxymethylcytosine Formation by a Carbocyclic 5‐Aza‐2′‐deoxy‐cytidine Antimetabolite
Maike Däther, Elsa Peev, Annika Fröhlich, Binje Vick, Sogol Fatourechi, Gilles Gasparoni, Matthias Heiss, Corinna C Pleintinger, Emmanuel Asu Bisong, Hans Hurmiz, Davide Guglielminotti, Yasmin V Gärtner, Tina Aumer, Karsten Spiekermann, Jörn Walter, Irmela Jeremias, Franziska R Traube, Thomas Carell · 2026
Read Increasing TET Expression and 5‐Hydroxymethylcytosine Formation by a Carbocyclic 5‐Aza‐2′‐deoxy‐cytidine Antimetabolite by Maike Däther, Elsa Peev, Annika Fröhlich, Binje Vick, Sogol Fatourechi, Gilles Gasparoni, Matthias Heiss, Corinna C Pleintinger, Emmanuel Asu Bisong, Hans Hurmiz, Davide Guglielminotti, Yasmin V Gärtner, Tina Aumer, Karsten Spiekermann, Jörn Walter, Irmela Jeremias, Franziska R Traube, Thomas Carell (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13427182.txt.
Description
Maike Däther and colleagues show a modified nucleoside drug can raise TET enzyme activity and hydroxymethylcytosine in cells in a 2026 epigenetics study. TET enzymes oxidize methylated cytosine in DNA to the hydroxymethyl form, reactivating genes silenced by promoter methylation. Aggressive cancers such as acute myeloid leukemia and glioblastoma often lose TET function, lowering hydroxymethyl marks and helping tumors develop.
Their carbocyclic 5-aza-2'-deoxycytidine antimetabolite increased TET expression and formation of the hydroxymethyl mark in the systems tested. Restoring an epigenetic eraser pharmacologically could reopen silenced tumor suppressor programs, a strategy distinct from blocking methylation outright. Lost marks of this kind are a hall mark of fast, hard to treat growths. The drug is a tweaked form of a known pill, so its path to test in man may be more swift than a brand new drug would face. The work was done in cells grown in the lab.
Catalog record
| CREATOR | Maike Däther, Elsa Peev, Annika Fröhlich, Binje Vick, Sogol Fatourechi, Gilles Gasparoni, Matthias Heiss, Corinna C Pleintinger, Emmanuel Asu Bisong, Hans Hurmiz, Davide Guglielminotti, Yasmin V Gärtner, Tina Aumer, Karsten Spiekermann, Jörn Walter, Irmela Jeremias, Franziska R Traube, Thomas Carell |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 25127 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |